Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil
Michael Gable of Fairmont Equities reports buying the dip remains a valid strategy for ResMed shares above new technical support of $40
The Chartist’s attention is back on lithium, through an ETF, with expectations building the renewed rally might not stop until a fresh all-time high is in place
Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil
Michael Gable of Fairmont Equities suggests CSL shares have found a bottom and seem destined for $300-plus yet again
The Chartist’s technical analysis suggests shares in BHP Group might have formed a significant low on price charts, now offering support
The Chartist notes how Telstra shares have embarked on a sharp uptrend, leaving no easy entry levels for traders
Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil
After two years of share price downtrend, Fairmont Equities’ Michael Gable reports Iluka Resources is signalling it’s time for investors to re-examine the stock
Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil